Unlocking the Evolutionary Mysteries Of Microbiome-Immune ...hmpdacc.org/doc/Sarkis...
Transcript of Unlocking the Evolutionary Mysteries Of Microbiome-Immune ...hmpdacc.org/doc/Sarkis...
Sarkis K Mazmanian, California Institute of Technology
Unlocking the Evolutionary MysteriesOf Microbiome-Immune Symbiosis
•Antibiotics ameliorate symptoms inhumans and animals•Germ-free animals do no develop IBDin several models
•No definitive pathogens identified
•Immune reactivity to commensal organisms
•Alterations in the microbiota of IBD patients
•Predicted defects in immune regulation
Bacteria play a critical role in inflammatory bowel disease (IBD)
The human gastrointestinal tract is populated by both harmful and beneficial bacteria
Pederson D, Cell Host & Microbe (2008)
•Bacteroides fragilis is a gram-negative, obligate anaerobic bacteria
•B. fragilis synthesizes at least eight unique capsular polysaccharide complexes from distinct genomic loci
•At least two of these polysaccharides (PSA and PSB) have anovel zwitterionic structure (both a positive and negative charge within each repeating subunit)
•B. fragilis is a prominent mutualist of in the human GI tract,
Polysaccharide A (PSA)
Experimental colitis is driven by inflammatory T-helper cells and prevented regulatory T cells
Neurath, M, Nature Medicine (2007)
PSA mediates the expansion of functionally suppressive CD4+CD25+Foxp3+ Tregs during colitis
Foxp3
Round & Mazmanian, PNAS (2010)
200nm 50nm 200nm 50nm
B. fragilis B. fragilis ∆PSA
PSA is selectively packaged into outer membrane vesicles of B. fragilis
Yue Shen
200nm 50nm 200nm 50nm
B. fragilis B. fragilis ∆PSA
100nm 100nm
∆PSA-OMVWT-OMVanti-PSB anti-PSG
OMV WC OMV WC
75
50
37
100
150
200
(kDa)
anti-PSA
WT ∆PSA
PSA is selectively packaged into outer membrane vesicles of B. fragilis
Yue Shen
*** ****
WT-OMV
∆PSA-OMV
PBS
EtOH
75
80
85
90
95
100
105
0 1 2 3 4
Days after TNBS Administration
EtOHPBS+TNBSWT-OMV+TNBSĘPSA-OMV+TNBS
EtOH PBS WT-OMV ĘPSA-OMV7
8
9
10
11
12
TNBS
***ns
***
OMVs containing PSA protect animals from colitis
*** ****
WT-OMV
∆PSA-OMV
PBS
EtOH
75
80
85
90
95
100
105
0 1 2 3 4
Days after TNBS Administration
EtOHPBS+TNBSWT-OMV+TNBSĘPSA-OMV+TNBS
EtOH PBS WT-OMV ĘPSA-OMV0
1
2
3
4
TNBS
***ns
EtOH PBS WT-OMV ĘPSA-OMV7
8
9
10
11
12
TNBS
***ns
***
EtOH
PBS
WT-OMV
∆PSA-OMV
OMVs containing PSA protect animals from colitis
•Helicobacter hepaticus is a gram-negative, microaerophilicspiral bacteria that colonizes mice
•H. hepaticus does not induce disease in wild-type animals,but upon chronic infection of immunocompromisedanimals causes intestinal inflammation with similarities toCrohn’s disease
Helicobacter hepaticus as a model pathobiont
Induction of H. hepaticus colitis is prevented by PSA treatment
C57bl/6 (wild-type)Rag2-/- +PBS+CD45RBhi
Rag2-/- +PBS+CD45RBhi
+H. hepaticus
Rag2-/- +PSA+CD45RBhi
+H. hepaticusRag2-/- +PBS+H. hepaticus
Mazmanian et al., Nature (2008)
Helicobacter hepaticus enters intestinal epithelial cells
Chow & Mazmanian, Cell Host & Microbe (2010)
T6SS mutants of Helicobacter hepaticus display increasedassociation with intestinal epithelial cells
CD4+ T cells from T6SS mutants of H. hepaticus exhibit increased pro-inflammatory responses
to intestinal epithelial cell-presented antigens
Round & Mazmanian, Nat Rev Immunol (2009)
Potential causes of dysbiosis due to ‘western’ lifestylesits role in intestinal health and disease
Genetics and Environment